133 related articles for article (PubMed ID: 33337391)
1. A case of neonatal diabetes insipidus following dexamethasone for bronchopulmonary dysplasia.
Eid H; Al Awad E; Yusuf K
J Neonatal Perinatal Med; 2021; 14(4):597-600. PubMed ID: 33337391
[TBL] [Abstract][Full Text] [Related]
2. Randomized Trial of 42-Day Compared with 9-Day Courses of Dexamethasone for the Treatment of Evolving Bronchopulmonary Dysplasia in Extremely Preterm Infants.
Marr BL; Mettelman BB; Bode MM; Gross SJ
J Pediatr; 2019 Aug; 211():20-26.e1. PubMed ID: 31349916
[TBL] [Abstract][Full Text] [Related]
3. Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001146. PubMed ID: 29063585
[TBL] [Abstract][Full Text] [Related]
4. Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants.
Shah SS; Ohlsson A; Halliday HL; Shah VS
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002057. PubMed ID: 29035425
[TBL] [Abstract][Full Text] [Related]
5. Central diabetes insipidus: A rare complication of IVH in a very low birth weight preterm infant.
Thakore P; Dunbar AE; Lindsay EB
J Neonatal Perinatal Med; 2019; 12(1):103-107. PubMed ID: 30530977
[TBL] [Abstract][Full Text] [Related]
6. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide.
Halliday HL; Patterson CC; Halahakoon CW;
Pediatrics; 2001 Feb; 107(2):232-40. PubMed ID: 11158452
[TBL] [Abstract][Full Text] [Related]
7. Early dexamethasone-attempting to prevent chronic lung disease.
Sinkin RA; Dweck HS; Horgan MJ; Gallaher KJ; Cox C; Maniscalco WM; Chess PR; D'Angio CT; Guillet R; Kendig JW; Ryan RM; Phelps DL
Pediatrics; 2000 Mar; 105(3 Pt 1):542-8. PubMed ID: 10699107
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone does not affect vasopressin release in bronchopulmonary dysplasia.
Zanardo V; Golin R; Chiozza ML; Faggian D
Pediatr Nephrol; 2000 Dec; 15(3-4):241-4. PubMed ID: 11149118
[TBL] [Abstract][Full Text] [Related]
9. Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001145. PubMed ID: 29063594
[TBL] [Abstract][Full Text] [Related]
10. Multicenter controlled clinical trial of high-frequency jet ventilation in preterm infants with uncomplicated respiratory distress syndrome.
Keszler M; Modanlou HD; Brudno DS; Clark FI; Cohen RS; Ryan RM; Kaneta MK; Davis JM
Pediatrics; 1997 Oct; 100(4):593-9. PubMed ID: 9310511
[TBL] [Abstract][Full Text] [Related]
11. [Glucocorticoide therapy in premature infants: French practices in 2006].
Autret-Leca E; Bauer S; Alberti C; Jonville-Béra AP; Aujard Y; Bensouda-Grimaldi L; Baud O
Arch Pediatr; 2009 Jul; 16(7):999-1004. PubMed ID: 19410441
[TBL] [Abstract][Full Text] [Related]
12. Extremely low-dose dexamethasone to facilitate extubation in mechanically ventilated preterm babies.
Tanney K; Davis J; Halliday HL; Sweet DG
Neonatology; 2011; 100(3):285-9. PubMed ID: 21701221
[TBL] [Abstract][Full Text] [Related]
13. Lipid intolerance in neonates receiving dexamethasone for bronchopulmonary dysplasia.
Amin SB; Sinkin RA; McDermott MP; Kendig JW
Arch Pediatr Adolesc Med; 1999 Aug; 153(8):795-800. PubMed ID: 10437750
[TBL] [Abstract][Full Text] [Related]
14. Delayed Dexamethasone Therapy and Neurodevelopmental Outcomes in Preterm Infants with Bronchopulmonary Dysplasia.
Lim G; Lee BS; Choi YS; Park HW; Chung ML; Choi HJ; Kim EA; Kim KS
Pediatr Neonatol; 2015 Aug; 56(4):261-7. PubMed ID: 25649722
[TBL] [Abstract][Full Text] [Related]
15. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
Bassler D
Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
[TBL] [Abstract][Full Text] [Related]
16. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.
Shah SS; Ohlsson A; Halliday HL; Shah VS
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002058. PubMed ID: 29041034
[TBL] [Abstract][Full Text] [Related]
17. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants.
Rastogi A; Akintorin SM; Bez ML; Morales P; Pildes RS
Pediatrics; 1996 Aug; 98(2 Pt 1):204-10. PubMed ID: 8692619
[TBL] [Abstract][Full Text] [Related]
18. Effects of prenatal steroids on water and sodium homeostasis in extremely low birth weight neonates.
Omar SA; DeCristofaro JD; Agarwal BI; La Gamma EF
Pediatrics; 1999 Sep; 104(3 Pt 1):482-8. PubMed ID: 10469773
[TBL] [Abstract][Full Text] [Related]
19. Pituitary-adrenal suppression and recovery in preterm very low birth weight infants after dexamethasone treatment for bronchopulmonary dysplasia.
Ng PC; Wong GW; Lam CW; Lee CH; Fok TF; Wong MY; Wong W; Chan DC
J Clin Endocrinol Metab; 1997 Aug; 82(8):2429-32. PubMed ID: 9253312
[TBL] [Abstract][Full Text] [Related]
20. Effect of dexamethasone treatment on serum GH, IGF-I, and the binding proteins IGFBP-1 and -3 in ventilated very preterm infants.
Huysman MW; Hokken-Koelega AC; Hop WC; Sauer PJ
Pediatr Res; 2003 Jul; 54(1):37-43. PubMed ID: 12646720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
